title: Aniracetam for treatment of patients with progressive supranuclear palsy.
authors.affiliation: Third Department of Internal Medicine, Yamanashi Medical College, Japan. nagasata@res.yamanashi-med.ac.jp
authors.forename: T
authors.initials: T
authors.lastname: Nagasaka
authors.forename: S
authors.initials: S
authors.lastname: Togashi
authors.forename: A
authors.initials: A
authors.lastname: Amino
authors.forename: K
authors.initials: K
authors.lastname: Nitta
authors.forename: K
authors.initials: K
authors.lastname: Shindo
authors.forename: Z
authors.initials: Z
authors.lastname: Shiozawa
mesh_terms: D000368:Aged; D004421:Dystonia; D004569:Electroencephalography; D005133:Eye Movements; D005260:Female; D005684:Gait; D006801:Humans; D008297:Male; D011760:Pyrrolidinones / Q000627:therapeutic use*; D013494:Supranuclear Palsy, Progressive / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D014956:Writing
chemical_list: D011760:Pyrrolidinones; C036466:aniracetam